|
Palo Alto, CA, June 15, 2004 — Telik, Inc. (Nasdaq:
TELK) announced that company management will present a corporate
update at the Third Annual Needham Biotechnology Conference on Thursday,
June 17, 2004 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time)
at the New York Palace Hotel in New York City. A live webcast of
the presentation will be accessible at Telik’s website, www.telik.com.
An archive of the webcast will be available on the Telik website
through June 24, 2004.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases including cancer. The company’s most advanced
drug development candidate is TELCYTA™. Telik’s product
candidates were discovered using its proprietary drug discovery
technology, TRAP, which enables the rapid and efficient discovery
of small molecule drug candidates. Additional information is available
at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
